Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-24-080929
Filing Date
2024-07-18
Accepted
2024-07-18 19:46:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2419796d1_sc13da.htm SC 13D/A 41269
  Complete submission text file 0001104659-24-080929.txt   42615
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Subject) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90395 | Film No.: 241125782
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 501 FIFTH AVENUE SUITE 1404 NEW YORK NY 10017
Business Address
Ianchulev Tsontcho (Filed by) CIK: 0001728916 (see all company filings)

Type: SC 13D/A